Ani Pharmaceuticals (ANIP)'s 30-day implied volatility (IV30) was 33.5% at the close on October 30, 2026, up from 33.4% the day before, against a 52-week range of 19.4% to 59.4%. Its 20-day historical volatility was 28.7%.
Data as of October 30, 2026.